Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroma, Acoustic 1 Neurofibromatosis 2 1 Meningioma 1 Ependymoma 1

Interventions

Specimen Handling 113 Magnetic Resonance Spectroscopy 113 Cyclophosphamide 106 pembrolizumab 82 Radiotherapy 79 Nivolumab 68 Cisplatin 67 fludarabine 64 Carboplatin 59 Biopsy 54 Standard of Care 46 Radiosurgery 43 Gemcitabine 43 Paclitaxel 42 Dexamethasone 41 Rituximab 37 Radiation 37 Doxorubicin 37 Blood Specimen Collection 37 Cytarabine 36 Bevacizumab 35 venetoclax 34 fludarabine phosphate 33 Surveys and Questionnaires 32 Temozolomide 31 Radiotherapy, Intensity-Modulated 31 Capecitabine 31 Practice Guidelines as Topic 28 Etoposide 28 Oxaliplatin 27

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × brigatinib × 30 days × Clear all

NCT04374305 2026-05-06

INTUITT-NF2

Massachusetts General Hospital

Phase 2 Recruiting

Ependymoma, Meningioma, Neuroma, Acoustic, Neurofibromatosis 2

Data powered by HemOnc (CC BY 4.0) Colophon ⚡